Bisphosphonate-related osteonecrosis of the jaw: clinical correlations with computerized tomography presentation

被引:32
作者
Elad, Sharon [1 ]
Gomori, Moshe J. [2 ]
Ben-Ami, Noa [1 ]
Friedlander-Barenboim, Silvina [1 ]
Regev, Eran [3 ]
Lazarovici, Towy S. [4 ]
Yarom, Noam [4 ,5 ]
机构
[1] Hebrew Univ Jerusalem, Dept Oral Med, Hadassah Sch Dent Med, IL-91120 Jerusalem, Israel
[2] Hadassah Univ, Dept Clin Radiol, Med Ctr, Jerusalem, Israel
[3] Hebrew Univ Jerusalem, Dept Oral & Maxillofacial Surg, Hadassah Sch Dent Med, IL-91120 Jerusalem, Israel
[4] Sheba Med Ctr, Dept Oral & Maxillofacial Surg, Tel Hashomer, Israel
[5] Tel Aviv Univ, Maurice & Gabriela Goldschleger Sch Dent Med, Dept Oral Pathol & Oral Med, IL-69978 Tel Aviv, Israel
关键词
Osteonecrosis; Bisphosphonate; Computerized tomography; Cortex; Mandibular canal; Diagnosis; Imaging; RISK-FACTORS; CANCER; FREQUENCY; NECROSIS; FEATURES;
D O I
10.1007/s00784-009-0311-3
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
The aim of this study was to correlate clinical and computerized tomography (CT) features of bisphosphonate-related osteonecrosis of the jaws (BRONJ). All ONJ patients for whom there was complete CT scan imaging were eligible. Selected clinical parameters retrieved from their medical records were analyzed for correlation with CT parameters. The clinical presentation of BRONJ was supported by findings in CT imaging in 78.3%. The lesion's size on CT correlated with the presence of purulent secretion (p = 0.03). When sequestrum was present, the median lesion's size on CT was relatively big (28 mm, range 21-43 mm). The mandibular canal cortex was never breached. CT has reasonable detection competence for diagnosing BRONJ. Purulent secretion indicates the likelihood that a more extensive involvement will be displayed on CT. A large lesion on CT should raise the index of suspicion for sequestrum. The CT appearance of a continuous cortex of the mandibular canal may serve as a differential parameter between BRONJ and metastasis to the jaw.
引用
收藏
页码:43 / 50
页数:8
相关论文
共 21 条
[2]  
*AM DENT ASS COUNC, 2006, J AM DENT ASSOC, V137, P1144
[3]   Osteonecrosis of the jaw in multiple myeloma patients: Clinical features and risk factors [J].
Badros, A ;
Weikel, D ;
Salama, A ;
Goloubeva, O ;
Schneider, A ;
Rapoport, A ;
Fenton, R ;
Gahres, N ;
Sausville, E ;
Ord, R ;
Meiller, T .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (06) :945-952
[4]   Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Incidence and risk factors [J].
Bamias, A ;
Kastritis, E ;
Bamia, C ;
Moulopoulos, LA ;
Melakopoulos, L ;
Bozas, G ;
Koutsoukou, V ;
Gika, D ;
Anagnostopoulos, A ;
Papadimitriou, C ;
Terpos, E ;
Dimopoulos, MA .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) :8580-8587
[5]   Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer [J].
Bianch, Silvio Diego ;
Scoletta, Matteo ;
Cassione, Francesca Bozzalla ;
Migliaretti, Giuseppe ;
Mozzati, Marco .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2007, 104 (02) :249-258
[6]  
Bisdas S, 2008, CLIN RADIOL, V63, P71, DOI 10.1016/j.crad.2007.04.023
[7]  
Durie BGM, 2005, NEW ENGL J MED, V353, P99
[8]  
Hoff AO, 2008, J BONE MINER RES, V23, P826, DOI [10.1359/JBMR.080205, 10.1359/jbmr.080205]
[9]   Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment [J].
Marx, RE ;
Sawatari, Y ;
Fortin, M ;
Broumand, V .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2005, 63 (11) :1567-1575